Evolent Health (EVH) Reports In-Line Q4 EPS, Beats on Revenues; Offers FY18 Revenue Guidance Below Consensus

Go back to Evolent Health (EVH) Reports In-Line Q4 EPS, Beats on Revenues; Offers FY18 Revenue Guidance Below Consensus
(NYSE: EVH) Delayed: 4.48 --0 (-0%)
Previous Close $4.48    52 Week High $26.84 
Open $4.48    52 Week Low $8.14 
Day High $4.48    P/E N/A 
Day Low $4.48    EPS $0.00 
Volume 455